Company Data

Baudax Bio Inc.

Fundamental Analysis:

Baudax Bio Inc.

Baudax Bio Inc.
Fundamental Analysis:
Ticker
BXRX
Current Price
$0.1455 4.45%
Market Cap
$2.9M
Price Target
Refer to Report
Volume
7.5M
52wk Range
$0.121 - $14.175
Advanced Market Data

Overview

Baudax Bio is a pharmaceutical company focused on innovative products for acute care settings. Baudax Bio markets ANJESO®, the first and only 24-hour, non-opioid, intravenous (IV) COX-2 preferential non-steroidal anti-inflammatory (NSAID) for the management of moderate to severe pain. In addition to ANJESO®, the Company has a pipeline of other innovative pharmaceutical assets including two clinical-stage, novel neuromuscular blocking (NMBs) agents and a proprietary chemical reversal agent specific to these NMBs.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2022 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.